Biodexa Pharmaceuticals (BDRX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
4.16
-0.08 (-1.89%)
At close: Jan 15, 2025, 11:24 AM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Cash & Equivalents | 5.97M | 2.84M | 10.06M | 7.55M | 10.93M | 2.34M | 13.20M | 17.61M | 16.18M | 30.32M | 2.39M | 133.00K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.00K | 49.00K |
Other Long-Term Assets | n/a | -837.00K | -1.15M | -542.00K | 2.63M | 469.00K | 465.00K | 448.00K | 387.00K | 425.00K | 379.00K | -927.00K |
Receivables | 704.00K | 329.00K | 33.00K | 95.00K | 22.00K | 89.00K | 2.23M | 1.43M | 985.00K | 189.00K | 160.00K | n/a |
Inventory | -704.00K | 1.00 | 1.00 | -1.38M | 1.00 | n/a | 941.00K | 817.00K | 459.00K | n/a | n/a | n/a |
Other Current Assets | 1.06M | 376.00K | 607.00K | 258.00K | 2.79M | 3.19M | 2.21M | 2.45M | 2.71M | 1.11M | 1.55M | 964.00K |
Total Current Assets | 7.03M | 4.69M | 11.76M | 9.28M | 13.74M | 5.62M | 18.58M | 22.30M | 20.33M | 31.63M | 4.09M | 1.10M |
Property-Plant & Equipment | 571.00K | 831.00K | 1.15M | 542.00K | 2.15M | 1.98M | 2.53M | 2.77M | 1.98M | 1.52M | 684.00K | 876.00K |
Goodwill & Intangibles | 2.94M | 6.00K | n/a | n/a | 12.38M | 12.37M | 27.65M | 31.17M | 41.34M | 13.09M | 4.00K | 2.00K |
Total Long-Term Assets | 3.51M | 837.00K | 1.15M | 542.00K | 17.16M | 14.83M | 30.64M | 34.39M | 43.71M | 15.04M | 1.08M | 927.00K |
Total Assets | 10.54M | 5.53M | 12.91M | 9.82M | 30.89M | 20.44M | 49.22M | 56.69M | 64.04M | 46.66M | 5.17M | 2.22M |
Account Payables | 314.00K | 339.00K | 485.00K | 337.00K | 725.00K | 286.00K | 2.27M | 3.27M | 2.29M | 981.00K | 522.00K | 563.00K |
Deferred Revenue | n/a | 197.00K | n/a | 68.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 169.00K | 161.00K | 146.00K | 200.00K | 412.00K | 368.00K | 361.00K | 538.00K | 442.00K | 491.00K | 1.25M | n/a |
Other Current Liabilities | 5.02M | 1.32M | 1.15M | 2.42M | 4.44M | 1.82M | 5.73M | 5.54M | 6.37M | 1.36M | 568.00K | 4.50M |
Total Current Liabilities | 5.57M | 1.90M | 1.84M | 2.99M | 5.67M | 2.47M | 8.36M | 9.35M | 9.10M | 2.83M | 2.29M | 5.07M |
Long-Term Debt | 295.00K | 463.00K | 620.00K | 60.00K | 5.67M | 884.00K | 6.18M | 1.62M | 1.51M | 1.49M | 2.12M | 2.17M |
Other Long-Term Liabilities | n/a | n/a | -469 | 50.00K | n/a | 165.00K | n/a | n/a | 6.55M | 354.00K | n/a | -2.17M |
Total Long-Term Liabilities | 295.00K | 463.00K | 619.53K | 110.00K | 5.67M | 1.05M | 6.18M | 1.62M | 8.05M | 1.84M | 2.12M | 2.17M |
Total Liabilities | 5.86M | 2.36M | 2.46M | 3.10M | 11.34M | 3.52M | 14.55M | 10.96M | 17.15M | 4.67M | 4.41M | 7.31M |
Total Debt | 464.00K | 624.00K | 766.00K | 260.00K | 6.08M | 1.17M | 6.51M | 2.13M | 1.88M | 1.94M | 3.32M | n/a |
Common Stock | 1.19M | 1.11M | 98.47K | 63.00K | 23.00K | 3.00K | 3.00K | 2.00K | 2.00K | 1K | n/a | n/a |
Retained Earnings | -144.77M | -135.34M | -127.80M | -122.43M | -99.84M | -89.72M | -74.65M | -59.11M | -39.15M | -29.22M | -20.40M | -17.19M |
Comprehensive Income | 61.52M | 53.00M | 53.00M | 53.00M | 53.49M | 53.70M | 56.39M | 57.62M | 54.39M | 39.57M | 142.00K | n/a |
Shareholders Equity | 4.68M | 3.16M | 10.45M | 6.72M | 19.56M | 16.92M | 34.68M | 45.72M | 46.89M | 41.99M | 760.00K | -5.09M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.00K | 49.00K |